Biotech pitch deck generator: pipeline, IND, clinical trial design
Biotech decks are different. Life-sciences VCs want pipeline maturity, IND/FDA status, clinical trial design, and capital efficiency — not B2B SaaS metrics. SlideGMM generates the 15-20 slide structure life-sciences investors expect.
Frequently asked questions
Everything past the team slide. Biotech replaces traction with pipeline maturity stages (preclinical → IND → Phase I/II/III). GTM becomes commercial strategy + payer access. Unit economics become capital efficiency + dilution forecast. Most biotech decks are 15-20 slides; SaaS decks are 12-15.
Less than B2B SaaS VCs. Biotech VCs are scientific-evidence-driven — they want validated mechanism of action, patent moat, and regulatory milestone clarity. Narrative-heavy decks underperform in biotech. SlideGMM's biotech template is data-first.
Visual phase-gate diagram (preclinical, IND, Phase I, II, III, NDA) with each program plotted. Color-coded by program. Annotation for timing of next IND filing and expected catalyst events. This is the most-read slide in biotech decks.